scholarly article | Q13442814 |
P356 | DOI | 10.1002/(SICI)1097-0142(19980615)82:12<2343::AID-CNCR7>3.0.CO;2-T |
P698 | PubMed publication ID | 9635526 |
P2093 | author name string | Hirata M | |
Murata H | |||
Hirasawa Y | |||
Hashiguchi S | |||
Takeshita H | |||
Ashihara T | |||
Kusuzaki K | |||
P2860 | cites work | An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide | Q34043489 |
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs | Q34662387 | ||
Genetic aspects of multidrug resistance | Q35264223 | ||
An assay to measure adriamycin binding in osteosarcoma cells | Q36724037 | ||
P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation | Q40546358 | ||
Doxorubicin: role in the treatment of osteosarcoma. | Q40709200 | ||
Tumor chemosensitivity and chemoresistance assays | Q40989319 | ||
Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). | Q41134729 | ||
Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines. | Q41225090 | ||
Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma | Q43530470 | ||
Rapid assays for evaluating the drug sensitivity of tumor cells | Q44215372 | ||
Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma | Q44672790 | ||
Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay. | Q52293243 | ||
Expression of the multidrug resistance gene in osteosarcoma: a pilot study. | Q54242131 | ||
Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patients. | Q54255049 | ||
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience | Q67530667 | ||
Surgical treatment and chemotherapy for pulmonary metastases from osteosarcoma | Q68031021 | ||
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarter | Q68780653 | ||
Use of nude mouse xenografts as preclinical drug screens. Further studies on in vitro growth of xenograft tumor colony-forming cells | Q69614676 | ||
Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy | Q70566496 | ||
Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy | Q70782481 | ||
Morphological changes in osteosarcoma after chemotherapy--COSS 80 | Q70911494 | ||
Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome | Q71523309 | ||
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival | Q72532464 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | doxorubicin | Q18936 |
preoperative chemotherapy | Q108532530 | ||
P304 | page(s) | 2343-2349 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma | |
P478 | volume | 82 |
Q36803686 | Global protein-expression analysis of bone and soft tissue sarcomas |
Q78148719 | Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas |
Q77910931 | Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas |
Q77910902 | Response of DNA ploidy to chemotherapy in primary and metastatic lesions in human osteosarcomas |
Search more.